CHRISTIAN S SCHADE Insider Trading $APRE Aprea Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for CHRISTIAN S SCHADE.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of CHRISTIAN S SCHADE. CHRISTIAN S SCHADE is Director in INTEGRA LIFESCIENCES HOLDINGS CORP ($IART) and SVP & CFO in MEDAREX INC ($MEDX) and Chairman & CEO in Aprea Therapeutics, Inc. ($APRE) and President & CEO in Aprea Therapeutics, Inc. ($APRE).

CHRISTIAN S SCHADE in Aprea Therapeutics, Inc.

Trading Symbol: APRE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CHRISTIAN S SCHADE: Chairman & CEO, President & CEO
Holdings: 77,160 shares
Latest Transaction: Mar 01 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of CHRISTIAN S SCHADE in Aprea Therapeutics, Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, APRE, IART, MEDX

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Mar 01 2021	APRE	Aprea Therapeutics ...	SCHADE CHRISTIAN S	Chairman & CEO	Option Exercise	A	6.00	329,000	1,974,000	329,000
Mar 01 2021	APRE	Aprea Therapeutics ...	SCHADE CHRISTIAN S	Chairman & CEO	Grant	A	0.00	88,500	0	176,660	88.2 K to 176.7 K (+100.39 %)
Mar 01 2021	APRE	Aprea Therapeutics ...	SCHADE CHRISTIAN S	Chairman & CEO	Grant	A	0.00	77,000	0	77,160	160 to 77.2 K (+48,125.00 %)
Mar 26 2020	APRE	Aprea Therapeutics ...	SCHADE CHRISTIAN S	President & CEO	Option Exercise	A	35.50	127,000	4,508,500	127,000
Oct 07 2019	APRE	Aprea Therapeutics ...	SCHADE CHRISTIAN S	President & CEO	Option Exercise	A	15.00	306,085	4,591,275	306,085
Oct 07 2019	APRE	Aprea Therapeutics ...	SCHADE CHRISTIAN S	President & CEO	Option Exercise	A	15.00	306,085	4,591,275	306,085
Oct 07 2019	APRE	Aprea Therapeutics ...	SCHADE CHRISTIAN S	President & CEO	Buy	P	15.00	5,000	75,000	5,000	0 to 5 K
Oct 07 2019	APRE	Aprea Therapeutics ...	SCHADE CHRISTIAN S	President & CEO	Buy	P	15.00	5,000	75,000	5,000	0 to 5 K
Oct 07 2019	APRE	Aprea Therapeutics ...	SCHADE CHRISTIAN S	President & CEO	Buy	P	15.00	1,000	15,000	1,000	0 to 1,000
Oct 07 2019	APRE	Aprea Therapeutics ...	SCHADE CHRISTIAN S	President & CEO	Buy	P	15.00	1,000	15,000	1,000	0 to 1,000
Oct 07 2019	APRE	Aprea Therapeutics ...	SCHADE CHRISTIAN S	President & CEO	Buy	P	15.00	1,000	15,000	1,000	0 to 1,000
Oct 07 2019	APRE	Aprea Therapeutics ...	SCHADE CHRISTIAN S	President & CEO	Buy	P	15.00	1,000	15,000	1,000	0 to 1,000
Oct 07 2019	APRE	Aprea Therapeutics ...	SCHADE CHRISTIAN S	President & CEO	Buy	P	15.00	1,000	15,000	1,000	0 to 1,000
Oct 07 2019	APRE	Aprea Therapeutics ...	SCHADE CHRISTIAN S	President & CEO	Buy	P	15.00	1,000	15,000	1,000	0 to 1,000
Oct 07 2019	APRE	Aprea Therapeutics ...	SCHADE CHRISTIAN S	President & CEO	Buy	P	15.00	1,000	15,000	1,000	0 to 1,000
Oct 07 2019	APRE	Aprea Therapeutics ...	SCHADE CHRISTIAN S	President & CEO	Buy	P	15.00	1,000	15,000	1,000	0 to 1,000
Oct 07 2019	APRE	Aprea Therapeutics ...	SCHADE CHRISTIAN S	President & CEO	Buy	P	15.00	1,000	15,000	1,000	0 to 1,000
Oct 07 2019	APRE	Aprea Therapeutics ...	SCHADE CHRISTIAN S	President & CEO	Buy	P	15.00	1,000	15,000	1,000	0 to 1,000
Oct 07 2019	APRE	Aprea Therapeutics ...	SCHADE CHRISTIAN S	President & CEO	Buy	P	15.00	1,000	15,000	1,000	0 to 1,000
Oct 07 2019	APRE	Aprea Therapeutics ...	SCHADE CHRISTIAN S	President & CEO	Buy	P	15.00	1,000	15,000	1,000	0 to 1,000

Page: 1